NO20003273L - Substituerte <beta>-alaniner - Google Patents
Substituerte <beta>-alaninerInfo
- Publication number
- NO20003273L NO20003273L NO20003273A NO20003273A NO20003273L NO 20003273 L NO20003273 L NO 20003273L NO 20003273 A NO20003273 A NO 20003273A NO 20003273 A NO20003273 A NO 20003273A NO 20003273 L NO20003273 L NO 20003273L
- Authority
- NO
- Norway
- Prior art keywords
- beta
- compounds
- prodrugs
- halogen
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyrrole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Polyamides (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9727532.5A GB9727532D0 (en) | 1997-12-23 | 1997-12-23 | Chemical compounds |
US9260298P | 1998-07-13 | 1998-07-13 | |
PCT/GB1998/003859 WO1999033789A1 (en) | 1997-12-23 | 1998-12-23 | SUBSTITUTED β-ALANINES |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20003273D0 NO20003273D0 (no) | 2000-06-22 |
NO20003273L true NO20003273L (no) | 2000-06-22 |
Family
ID=26312873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20003273A NO20003273L (no) | 1997-12-23 | 2000-06-22 | Substituerte <beta>-alaniner |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1042279B1 (no) |
JP (1) | JP4555469B2 (no) |
KR (1) | KR20010033520A (no) |
CN (1) | CN1163477C (no) |
AT (1) | ATE289991T1 (no) |
AU (1) | AU747907B2 (no) |
BR (1) | BR9814376A (no) |
CA (1) | CA2316235A1 (no) |
CZ (1) | CZ20002342A3 (no) |
DE (1) | DE69829215T2 (no) |
ES (1) | ES2235383T3 (no) |
HK (1) | HK1034508A1 (no) |
HU (1) | HUP0101701A3 (no) |
IL (1) | IL136584A (no) |
NO (1) | NO20003273L (no) |
NZ (1) | NZ505363A (no) |
SK (1) | SK9372000A3 (no) |
TR (1) | TR200001947T2 (no) |
WO (1) | WO1999033789A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1049665A1 (en) * | 1998-01-23 | 2000-11-08 | Novartis AG (Novartis SA) (Novartis Inc.) | Vla-4 antagonists |
ES2297943T3 (es) * | 1998-12-23 | 2008-05-01 | Aventis Pharma Limited | Dihidro-benzo(1,4)oxacinas y tetrahidroquinoxalinas. |
CN1213025C (zh) * | 1999-02-18 | 2005-08-03 | 霍夫曼-拉罗奇有限公司 | 硫代酰胺衍生物 |
SK8692002A3 (en) | 1999-12-28 | 2003-06-03 | Pfizer Prod Inc | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
DE10019755A1 (de) * | 2000-04-20 | 2001-11-08 | Bayer Ag | Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten |
FR2812633A1 (fr) * | 2000-08-04 | 2002-02-08 | Aventis Cropscience Sa | Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides |
GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
GB2367816A (en) | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
EP1330432A2 (en) | 2000-11-04 | 2003-07-30 | Aventis Pharma Limited | Substituted alkanoic acids |
US7157487B2 (en) | 2000-12-28 | 2007-01-02 | Daiichi Pharmaceutical Co., Ltd. | Vla-4 inhibitors |
GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
EP1650205B1 (en) | 2003-07-24 | 2012-04-25 | Daiichi Sankyo Company, Limited | Cyclohexanecarboxylic acid compound |
JP2008539246A (ja) * | 2005-04-28 | 2008-11-13 | フェリング ベスローテン フェンノートシャップ | Ibd治療のための新規化合物の使用 |
EP1961750B1 (en) | 2005-12-13 | 2013-09-18 | Daiichi Sankyo Company, Limited | Vla-4 inhibitory drug |
US20100150915A1 (en) | 2007-02-20 | 2010-06-17 | Stewart Edward J | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
NZ318926A (en) * | 1995-08-30 | 1999-04-29 | Searle & Co | Alpha v beta 3 integrin (vitronectin) inhibitors or anatagonists derived from benzoic acid for treating diseases of cell adhesion |
AU2536097A (en) * | 1996-03-29 | 1997-10-22 | G.D. Searle & Co. | Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
DK0889877T3 (da) * | 1996-03-29 | 2001-10-01 | Searle & Co | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer |
KR20010031557A (ko) * | 1997-10-31 | 2001-04-16 | 추후제출 | 치환 아닐리드 |
-
1998
- 1998-12-23 KR KR1020007007022A patent/KR20010033520A/ko not_active Application Discontinuation
- 1998-12-23 HU HU0101701A patent/HUP0101701A3/hu unknown
- 1998-12-23 AU AU17719/99A patent/AU747907B2/en not_active Ceased
- 1998-12-23 NZ NZ505363A patent/NZ505363A/en unknown
- 1998-12-23 DE DE69829215T patent/DE69829215T2/de not_active Expired - Lifetime
- 1998-12-23 IL IL13658498A patent/IL136584A/xx not_active IP Right Cessation
- 1998-12-23 EP EP98962586A patent/EP1042279B1/en not_active Expired - Lifetime
- 1998-12-23 ES ES98962586T patent/ES2235383T3/es not_active Expired - Lifetime
- 1998-12-23 CZ CZ20002342A patent/CZ20002342A3/cs unknown
- 1998-12-23 BR BR9814376-0A patent/BR9814376A/pt not_active Application Discontinuation
- 1998-12-23 SK SK937-2000A patent/SK9372000A3/sk unknown
- 1998-12-23 AT AT98962586T patent/ATE289991T1/de not_active IP Right Cessation
- 1998-12-23 CN CNB988125005A patent/CN1163477C/zh not_active Expired - Fee Related
- 1998-12-23 CA CA002316235A patent/CA2316235A1/en not_active Abandoned
- 1998-12-23 TR TR2000/01947T patent/TR200001947T2/xx unknown
- 1998-12-23 WO PCT/GB1998/003859 patent/WO1999033789A1/en active Search and Examination
- 1998-12-23 JP JP2000526473A patent/JP4555469B2/ja not_active Expired - Lifetime
-
2000
- 2000-06-22 NO NO20003273A patent/NO20003273L/no not_active Application Discontinuation
-
2001
- 2001-07-27 HK HK01105254A patent/HK1034508A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010033520A (ko) | 2001-04-25 |
HUP0101701A2 (hu) | 2001-11-28 |
BR9814376A (pt) | 2000-10-10 |
WO1999033789A1 (en) | 1999-07-08 |
NO20003273D0 (no) | 2000-06-22 |
HUP0101701A3 (en) | 2003-02-28 |
CN1163477C (zh) | 2004-08-25 |
JP2001527061A (ja) | 2001-12-25 |
IL136584A0 (en) | 2001-06-14 |
DE69829215T2 (de) | 2005-07-21 |
AU747907B2 (en) | 2002-05-30 |
TR200001947T2 (tr) | 2001-01-22 |
AU1771999A (en) | 1999-07-19 |
SK9372000A3 (en) | 2002-03-05 |
CZ20002342A3 (cs) | 2001-11-14 |
HK1034508A1 (en) | 2001-10-26 |
NZ505363A (en) | 2005-02-25 |
EP1042279A1 (en) | 2000-10-11 |
CA2316235A1 (en) | 1999-07-08 |
CN1283181A (zh) | 2001-02-07 |
ES2235383T3 (es) | 2005-07-01 |
JP4555469B2 (ja) | 2010-09-29 |
IL136584A (en) | 2005-03-20 |
DE69829215D1 (de) | 2005-04-07 |
ATE289991T1 (de) | 2005-03-15 |
EP1042279B1 (en) | 2005-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE289991T1 (de) | Substituierte beta-alaninen | |
DK1027328T3 (da) | Substituerede anilider | |
DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
TR200102959T2 (tr) | İntegrin antagonistleri olarak ikame edilmiş bisiklik heteroaril bileşikleri | |
HUP0204496A2 (en) | Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same | |
IT1295694B1 (it) | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica | |
SE9604786D0 (sv) | New compounds | |
IL151172A0 (en) | Amine derivatives, their preparation and use as bax modulators | |
DE60012048D1 (de) | Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung | |
ZA953981B (en) | New azolidinediones as antihyperglycemic agents | |
CO4820432A1 (es) | Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina | |
ATE165368T1 (de) | Inhibitoren von testosteron-5-alpha reductase. | |
NO944892L (no) | N-substituerte 3-azabicyklo (3.2.0) hepatanderivater som neuroleptika osv. | |
DE69204041D1 (de) | Thiazolidinverbindeungen, deren Herstellung und therapeutische Verwendung. | |
HUP0102025A2 (hu) | Diaril-1,3,4-oxadiazolon-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
DE69512208D1 (de) | Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren | |
DE69402935D1 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
PT89082A (pt) | Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico | |
DE69902766D1 (de) | N-aryloxyethylaminderivate zur behandlung der depression | |
EP0638564A4 (en) | BENZOTHIAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND APPLICATION THEREOF. | |
NO950177L (no) | Farmakologisk aktive erivater | |
BR9808234A (pt) | Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas para a produção de uma composição farmacêutica para o tratamento de distúrbios do sono | |
PT850225E (pt) | Intermediario para preparar um composto farmaceuticamente activo | |
DE69400908D1 (de) | Verwendung von riluzol zum schutz gegen strahlenschäden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |